-
Thematic Analysis
Internet of Things (IoT) in Media – Thematic Intelligence
Internet of Things (IoT) in Media Thematic Report Overview The Internet of Things (IoT) refers to the use of connected sensors and actuators to control and monitor the environment, the things that move within it, and the people that act within it. IoT remains invaluable for media as it can be used for connecting devices and collecting user data to create more customized and engaging experiences, cut costs, and enhance the efficiency of operations. The Internet of Things (IoT) in...
-
Product Insights
Vascular Access Devices for Hemodialysis Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Vascular Access Devices for Hemodialysis Pipeline Market Report Overview Vascular Access Devices for Hemodialysis include AV Fistula Needles, Grafts, Vascular Covered Stents, and Hemodialysis Catheters. The Vascular Access Devices for Hemodialysis pipeline market research report provides comprehensive information about the Vascular Access Devices for Hemodialysis pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Territories ·       The US ·       China ·       Europe ·       Global...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sirolimus in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus in Pulmonary Arterial Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sirolimus in Pulmonary Arterial Hypertension Drug Details: Sirolimus is under development...
-
Sector Analysis
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sirolimus in Bronchiolitis Obliterans
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus in Bronchiolitis Obliterans report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Sirolimus in Bronchiolitis Obliterans Drug Details: Sirolimus is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sirolimus in Lymphangioleiomyomatosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus in Lymphangioleiomyomatosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sirolimus in Lymphangioleiomyomatosis Drug Details: Sirolimus is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sirolimus in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus in Pulmonary Arterial Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sirolimus in Pulmonary Arterial Hypertension Drug Details: Sirolimus is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sirolimus in Pulmonary Sarcoidosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus in Pulmonary Sarcoidosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sirolimus in Pulmonary Sarcoidosis Drug Details: Sirolimus is under development for the...
-
Product Insights
Self Help Ent – Guardian Village Housing Community – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our Self Help Ent – Guardian Village Housing Community – California report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough understanding of...
-
Product Insights
United Kingdom (UK) Travel Insurance Market Dynamics, Trends and Opportunities
United Kingdom (UK) Travel Insurance Market Report Overview The UK travel insurance market witnessed a substantial increase in GWP reaching GBP 630.4 million in 2022. While the increase in GWP was substantial, it occurred in the context of a decrease in the number of policyholders. This suggests that growth in GWP is not due to increased demand but rather a result of higher premiums being charged. The market is expected to achieve a CAGR of more than 2% during 2022-2027. UK...